Mckesson (MCK) Free Cash Flow Growth (3y) (2012 - 2026)
Mckesson (MCK) Free Cash Flow Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Akso Health | 2,315,158.81 Bn | 2,315,158.63 Bn | - | - |
| 2 | Mckesson | 92.76 Bn | 89.18 Bn | 4.04 Bn | 0.80% |
| 3 | Cencora | 52.82 Bn | 50.83 Bn | 3.59 Bn | 30.60% |
| 4 | Cardinal Health | 52.17 Bn | 48.39 Bn | 2.50 Bn | 10.23% |
| 5 | Henry Schein | 9.19 Bn | 9.71 Bn | 1.07 Bn | -212.44% |
| 6 | Accendra Health | 246.88 Mn | -90.00 Mn | 312.39 Mn | -45.61% |
| 7 | Edap Tms | 161.92 Mn | 146.92 Mn | 8.15 Mn | -3.17% |
| 8 | 111 | 107.47 Mn | 25.61 Mn | 23.58 Mn | -22.47% |
| 9 | Cosmos Health | 9.42 Mn | 7.26 Mn | 1.38 Mn | 44.68% |
| 10 | Cellyan Biotechnology | 5.69 | -2.48 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.80% |
| Dec 31, 2025 | -10.86% |
| Sep 30, 2025 | 32.57% |
| Jun 30, 2025 | -0.89% |
| Mar 31, 2025 | 36.66% |
| Dec 31, 2024 | -57.87% |
| Sep 30, 2024 | 2.83% |
| Jun 30, 2024 | 5.14% |
| Mar 31, 2024 | 5.98% |
| Dec 31, 2023 | -45.46% |
| Sep 30, 2023 | -4.17% |
| Jun 30, 2023 | 0.27% |
| Mar 31, 2023 | -10.34% |
| Dec 31, 2022 | 96.78% |
| Sep 30, 2022 | 143.25% |
| Jun 30, 2022 | -91.56% |
| Mar 31, 2022 | -9.76% |
| Dec 31, 2021 | 81.22% |
| Sep 30, 2021 | 10.67% |
| Jun 30, 2021 | -13.25% |